BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9034146)

  • 1. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase.
    Nakamura MC; Niemi EC; Fisher MJ; Shultz LD; Seaman WE; Ryan JC
    J Exp Med; 1997 Feb; 185(4):673-84. PubMed ID: 9034146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line.
    Motoda K; Takata M; Kiura K; Nakamura I; Harada M
    Immunology; 2000 Jul; 100(3):370-7. PubMed ID: 10929060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase.
    Mason LH; Gosselin P; Anderson SK; Fogler WE; Ortaldo JR; McVicar DW
    J Immunol; 1997 Nov; 159(9):4187-96. PubMed ID: 9379012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    Lowin-Kropf B; Kunz B; Beermann F; Held W
    J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.
    Binstadt BA; Brumbaugh KM; Dick CJ; Scharenberg AM; Williams BL; Colonna M; Lanier LL; Kinet JP; Abraham RT; Leibson PJ
    Immunity; 1996 Dec; 5(6):629-38. PubMed ID: 8986721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ly-49P activates NK-mediated lysis by recognizing H-2Dd.
    Silver ET; Gong DE; Chang CS; Amrani A; Santamaria P; Kane KP
    J Immunol; 2000 Aug; 165(4):1771-81. PubMed ID: 10925254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
    Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
    J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
    Nakamura MC; Linnemeyer PA; Niemi EC; Mason LH; Ortaldo JR; Ryan JC; Seaman WE
    J Exp Med; 1999 Feb; 189(3):493-500. PubMed ID: 9927511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.
    Orihuela M; Margulies DH; Yokoyama WM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11792-7. PubMed ID: 8876216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft.
    Waldenström M; Sundbäck J; Olsson-Alheim MY; Achour A; Kärre K
    Eur J Immunol; 1998 Sep; 28(9):2872-81. PubMed ID: 9754574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
    Le Dréan E; Vély F; Olcese L; Cambiaggi A; Guia S; Krystal G; Gervois N; Moretta A; Jotereau F; Vivier E
    Eur J Immunol; 1998 Jan; 28(1):264-76. PubMed ID: 9485206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.
    Mason LH; Willette-Brown J; Mason AT; McVicar D; Ortaldo JR
    J Immunol; 2000 Jan; 164(2):603-11. PubMed ID: 10623801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain.
    Daniels BF; Nakamura MC; Rosen SD; Yokoyama WM; Seaman WE
    Immunity; 1994 Dec; 1(9):785-92. PubMed ID: 7895167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.
    Brennan J; Mager D; Jefferies W; Takei F
    J Exp Med; 1994 Dec; 180(6):2287-95. PubMed ID: 7964501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.